6:09 AM ET
10-Q
Financial Results
Scienture Holdings Q3 2026 Results: Net Loss of $6.01M, Loss Widens
Scienture Holdings, Inc. reported a net loss of $12.2 million for the nine months ended September 30, 2026, compared to a $13.4 million loss in the prior year. While revenues increased significantly to $1.65 million, the company remains focused on R&D and specialty pharmaceutical development following its acquisition of Scienture, LLC and the disposition of legacy subsidiaries.
- Key figure
- Net loss $6.01M